Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2022-12-27 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
北京大成（广州）律师事务所关于惠州市锦好医疗科技股份有限公司2022年股票期权与限制性股票激励计划预留部分授予事项法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2022 stock option and restricted stock incentive plan reserved portion grant matters of Huizhou Jinhao Medical Technology Co., Ltd. It discusses legal compliance, approvals, authorizations, and conditions related to the stock incentive plan. The document is not a financial report, earnings release, or regulatory filing about financial results. It is a specialized legal opinion related to corporate governance and stock incentive plans. This type of document does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a proxy solicitation or voting result announcement. It is a legal proceeding or advisory document related to corporate governance and stock incentive plans. Given the options, the best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not neatly fit into other categories, especially legal opinions related to corporate actions and compliance.
2022-12-27 Chinese
2022年第六次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2022 sixth extraordinary general meeting of shareholders of Huizhou Jin Hao Medical Technology Co., Ltd. It includes information about the meeting date, attendance, voting results on specific proposals, and legal opinions on the meeting's validity. The content focuses on shareholder meeting decisions and voting outcomes rather than financial results or management changes. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 1729 characters, which is consistent with a detailed voting results announcement rather than a full report or a brief notice. Therefore, the appropriate classification is DVA with high confidence.
2022-12-21 Chinese
广东东方昆仑（东莞）律师事务所关于惠州市锦好医疗科技股份有限公司2022年第六次临时股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, qualifications, and voting results of the 2022 sixth extraordinary general meeting (临时股东大会) of Huizhou Jin Hao Medical Technology Co., Ltd. It details the legality and compliance of the meeting's call, attendance, and voting process. The document is not a financial report, earnings release, or management discussion. It is a legal opinion related to a shareholders' meeting and the voting results. This type of document aligns best with the category 'Declaration of Voting Results & Voting Rights Announcements (DVA)', as it officially reports the voting results and legality of the shareholder meeting proceedings. The document length is under 5,000 characters and contains substantive content, not just an announcement of a report, so it is not an RPA. Therefore, the classification is DVA with high confidence.
2022-12-21 Chinese
关于认定核心员工的公告
Board/Management Information Classification · 95% confidence The document is an announcement from Huizhou Jin Hao Medical Technology Co., Ltd. regarding the recognition of core employees. It details the approval process by the board of directors, supervisory board, and shareholders' meeting, listing the names of the core employees. There is no financial data, audit information, or report publication mentioned. The content focuses on management and personnel decisions related to key employees, which aligns with announcements about board or management information. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short and does not indicate it is a report or financial statement, so it is not an Annual Report or Interim Report. Hence, the classification is MANG with high confidence.
2022-12-21 Chinese
关于监事会对拟认定核心员工及预留权益授予激励对象名单的核查意见公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the supervisory board regarding the verification and approval of the list of core employees and reserved equity incentive recipients under the company's 2022 equity incentive plan. It references compliance with company law, listing rules, and internal governance documents. The content focuses on the supervisory board's opinion and confirmation of the legitimacy and compliance of the incentive recipients. There are no financial statements, earnings data, or detailed financial analysis present. The document is a regulatory announcement related to governance and compliance of employee incentive plans rather than a full management report or remuneration report. It does not fit the categories of Annual Report, Management Report, or Remuneration Information. It is also not a proxy solicitation or voting result announcement. Given the nature of the content and the absence of financial data, the best fitting category is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other specific categories. The document length is short (1819 characters), consistent with an announcement rather than a full report.
2022-12-14 Chinese
拟续聘会计师事务所公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (auditor) for the company's 2022 annual audit. It details the auditor's qualifications, independence, and the board's approval process. There are no financial statements or audit results included, only information about the auditor and the approval process. The document is relatively short (2853 characters) and serves as a formal announcement rather than the audit report itself. Therefore, it fits the category of Audit Report / Information (AR), which includes standalone audit reports and related information about auditors, but not the full annual report or audit results. FY 2022
2022-12-04 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.